Vous n'êtes pas identifié (connexion)

Centre de recherche

MARDI 26 SEP

Kiosque de compagnie

Exposition de produits FroggaBio

Calendrier >

BOTTIN

Frédéric Barabé

Formation
à venir

Aucune offre active

Autres opportunités de carrière
Axe principal
Maladies infectieuses et immunitaires
Adresse(s)
Centre Hospitalier de l'Université Laval (CHUL)
2705, boulevard Laurier
RC-709
Québec (Québec)
CANADA G1V 4G2

Téléphone(s)
+1 418-525-4444, poste 47677
Télécopieur(s)
+1 418-654-2715
Courriel(s)
Frederic.Barabe@crchudequebec.ulaval.ca

Projet(s) de recherche reconnu(s) par l'Université Laval

Autre(s) projet(s) de recherche actif(s)

Aucun projet de recherche à afficher

Publications récentes (voir toutes les publications de ce chercheur)

Barabe F, Gil L, Celton M, Bergeron A, Lamontagne V, Roques E, Lagace K, Forest A, Johnson R, Pecheux L, Simard J, Pelloux J, Bellemare-Pelletier A, Gagnon E, Hebert J, Cellot S, Wilhelm BT. Modeling human MLL-AF9 translocated acute myeloid leukemia from single donors reveals RET as a potential therapeutic target. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K ,  2017. 31: 1166-1176
Laouedj M, Tardif MR, Gil L, Raquil MA, Lachaab A, Pelletier M, Tessier PA, Barabe F. S100A9 induces differentiation of acute myeloid leukemia cells through TLR4. Blood,  2017. Epub
Pabst C, Bergeron A, Lavallee VP, Yeh J, Gendron P, Norddahl GL, Krosl J, Boivin I, Deneault E, Simard J, Imren S, Boucher G, Eppert K, Herold T, Bohlander SK, Humphries K, Lemieux S, Hebert J, Sauvageau G, Barabe F. GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivo. Blood,  2016. 127: 2018-27
Bobbala D, Kandhi R, Chen X, Mayhue M, Bouchard E, Yan J, Knecht H, Barabe F, Ramanathan S, Ilangumaran S. Interleukin-15 deficiency promotes the development of T-cell acute lymphoblastic leukemia in non-obese diabetes mice with severe combined immunodeficiency. Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K ,  2016. 30: 1749-52
Furrer D, Lemieux J, Cote MA, Provencher L, Laflamme C, Barabe F, Jacob S, Michaud A, Diorio C. Evaluation of human epidermal growth factor receptor 2 (HER2) single nucleotide polymorphisms (SNPs) in normal and breast tumor tissues and their link with breast cancer prognostic factors. Breast (Edinburgh, Scotland) ,  2016. 30: 191-196
Lavallee VP, Baccelli I, Krosl J, Wilhelm B, Barabe F, Gendron P, Boucher G, Lemieux S, Marinier A, Meloche S, Hebert J, Sauvageau G. The transcriptomic landscape and directed chemical interrogation of MLL-rearranged acute myeloid leukemias. Nature genetics,  2015. 47: 1030-7
Bordeleau ME, Aucagne R, Chagraoui J, Girard S, Mayotte N, Bonneil E, Thibault P, Pabst C, Bergeron A, Barabe F, Hebert J, Sauvageau M, Boutonnet C, Meloche S, Sauvageau G. UBAP2L is a novel BMI1-interacting protein essential for hematopoietic stem cell activity. Blood,  2014. 124: 2362-9
Lemieux J, Diorio C, Cote MA, Provencher L, Barabe F, Jacob S, St-Pierre C, Demers E, Tremblay-Lemay R, Nadeau-Larochelle C, Michaud A, Laflamme C. Alcohol and HER2 polymorphisms as risk factor for cardiotoxicity in breast cancer treated with trastuzumab. Anticancer research,  2013. 33: 2569-76
Deneault E, Wilhelm BT, Bergeron A, Barabe F, Sauvageau G. Identification of non-cell-autonomous networks from engineered feeder cells that enhance murine hematopoietic stem cell activity. Experimental hematology,  2013. 41: 470-478.e4
Black L, Avard D, Zawati MH, Knoppers BM, Hebert J, Sauvageau G, Leucegene Project. Funding considerations for the disclosure of genetic incidental findings in biobank research. Clinical genetics,  2013. 84: 397-406
© 2017 Tous droits réservés Centre de recherche du CHU de Québec